Verrica Pharmaceuticals Inc (NASDAQ:VRCA)

3.26
Delayed Data
As of 3:59pm ET
 -0.16 / -4.68%
Today’s Change
1.77
Today|||52-Week Range
14.79
-64.41%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$126.5M

Company Description

Verrica Pharmaceuticals, Inc. engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its lead product candidate VP-102, is a proprietary topical therapy used in common skin indications including molluscum contagiosum and verruca vulgaris. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.

Contact Information

Verrica Pharmaceuticals, Inc.
44 West Gay Street
West Chester Pennsylvania 19380
P:(434) 453-3300
Investor Relations:

Employees

Shareholders

Individual stakeholders60.36%
Other institutional23.93%
Mutual fund holders11.67%

Top Executives

Ted WhitePresident, Chief Executive Officer & Director
Terry KohlerChief Financial & Accounting Officer
Gary GoldenbergChief Medical Officer
Eugene ScavolaExecutive Vice President-Technical Operations
Christopher G. HayesSecretary, Chief Legal & Compliance Officer